Presepsin对腹部手术脓毒症的预后价值:一项前瞻性研究
该前瞻性研究纳入2014年3月至8月因腹腔感染行急诊手术的31例患者,采用Sepsis-2和Sepsis-3定义,术前检测presepsin、内毒素、C反应蛋白、降钙素原(PCT)、白介素6(IL-6)和白细胞计数并与临床病程及死亡率进行相关性分析。20例(64.5%)患者发生腹腔来源脓毒症。presepsin对脓毒症发生的曲线下面积、敏感性和特异性最高,对死亡的预测价值也高于内毒素及PCT、IL-6等既往标志物。包含PCT、IL-6和presepsin的多标志物联合方案未显示出优于presepsin单用的额外预测价值。作者认为presepsin是腹腔感染手术患者脓毒症及脓毒症死亡的新预测标志物,但需在更大队列中验证。
要点
- 在31例因腹腔感染行急诊手术的患者中,20例(64.5%)发生腹腔来源脓毒症。
- 术前presepsin对脓毒症发生的曲线下面积、敏感性和特异性在所有分析的血标志物中最高。
- presepsin对死亡的预测价值高于内毒素、PCT和IL-6。
- PCT、IL-6和presepsin三标志物联合未比presepsin单用提供额外预测价值。
- 作者认为presepsin是腹腔感染手术患者脓毒症及死亡的新预测标志物,但需在更大队列中验证。
适用人群与场景
- 2014年3月至8月因腹腔感染行急诊手术的31例患者。
诊断标准与关键阈值
- 采用Sepsis-2和Sepsis-3脓毒症定义。
研究设计与关键结果
- 前瞻性研究,纳入31例因腹腔感染行急诊手术的患者,20例(64.5%)发生腹腔来源脓毒症。
- 术前检测presepsin、内毒素、C反应蛋白、PCT、IL-6和白细胞计数并与临床病程及死亡率进行相关性分析。
- presepsin对脓毒症发生的曲线下面积、敏感性和特异性在所有分析的血标志物中最高。
- presepsin对死亡的预测价值高于内毒素、PCT和IL-6。
- 包含PCT、IL-6和presepsin的多标志物联合方案未显示出优于presepsin单用的额外预测价值。
证据类型、等级与局限
- 证据类型:前瞻性研究。
- 局限:原文指出本研究结果需在更大队列中验证。
对床旁实践的改变
- 作者认为presepsin是腹腔感染手术患者脓毒症及脓毒症死亡的新预测标志物,但需在更大队列中验证。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
INTRODUCTION: Rapid diagnosis accompanied by appropriate treatment is essential in the therapy of sepsis. However, there is no blood marker available, which reliably predicts sepsis and associated mortality. Therefore, the aim of the present study was to evaluate presepsin and endotoxin in comparison with established blood markers in patients undergoing emergency visceral surgery for abdominal infection.
PATIENTS AND METHODS: This prospective study included 31 patients with abdominal infection undergoing emergency surgery between March and August 2014. The Sepsis-2 and Sepsis-3 definitions of sepsis were used. Blood markers (presepsin, endotoxin, C-reactive protein, procalcitonin (PCT), interleukin 6 (IL-6), white blood count) were analyzed preoperatively and correlated with the clinical course and mortality. Additionally, a combination of the three markers, which performed best, was tested.
RESULTS: Twenty patients (64.5%) in the analyzed cohort developed sepsis from an abdominal focus according to the latest sepsis definition. Out of the analyzed blood markers, presepsin exhibited the highest area under the curve, sensitivity, and specificity for the prediction of the development of sepsis. Moreover, presepsin had the highest predictive value for mortality as opposed to both endotoxin and previously established blood markers (i.e., PCT, IL-6). The multimarker approach, which included PCT, IL-6, and presepsin, showed no additional predictive value over presepsin alone.
CONCLUSION: The present study suggests that presepsin is a novel predictor of sepsis and mortality from sepsis in patients undergoing surgery for intra-abdominal infections. The findings of the present study should be validated in a larger cohort.
参考来源
- Bösch F, Schallhorn S, Miksch RC, et al. The Prognostic Value of Presepsin for Sepsis in Abdominal Surgery: A Prospective Study. Shock. 2020. PMID: 31743301. doi:10.1097/SHK.0000000000001479
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。